DIRS.INFO The most relevant business & tech news

☆ The UAE is a global leader in diamond trading. Now, it wants to grow them, too
▼ + stars: | 2024-03-06 | by ( Ana De Oliva | ) edition.cnn.com time to read: +7 min

The United Arab Emirates (UAE) is a global leader in diamond imports and exports, but it does not have any diamond mines. In 2022, he co-founded Dubai-based 2DOT4 Diamonds, becoming the first to produce, cut, and polish lab-grown diamonds in the UAE. “The mined diamond, you don’t control it, the Earth is doing it.”To grow a diamond, you start with a diamond, either lab-grown or mined, explains Sabeg. Last year, the country underwent a tax reform in the sector and pledged extra funding to further expand its man-made diamond industry. “Sixty years ago, if you tell someone this is a synthetic or a lab-grown diamond, they won’t even look at it,” he adds.

Persons: CNN —, Mohamed Sabeg, ”, ” Mohamed Sabeg, Paul Devitt, It’s, Everest —, CNN “, Paul Zimnisky, Ahmed Bin Sulayem, Bin Sulayem, “, Zimnisky Organizations: CNN, International Gem Society, United Arab Emirates, Dubai Multi Commodities Center, HRA Locations: Russia, South Africa, UAE, Dubai, 2DOT4, US, China, India, CNN India, Emirate

☆ Struggling insurance upstart Oscar is making a long shot bet on a Trump-era program to fuel growth
▼ + stars: | 2024-01-16 | by ( ) www.businessinsider.com time to read: +6 min

The New York insurance company has struggled to find its footing for years. At the top of the list is this little-known Trump-era policy, which offered employers a new way to give workers health benefits. Oscar has struggled with deep lossesBertolini is the former CEO of the insurance company Aetna. The company raised its health plans' prices and renegotiated contracts with healthcare providers and vendors — including its pharmacy-benefit manager — to lower expenses. In the future, Oscar plans to design specific health plans that cater to those types of customers.

Persons: —, Joshua Kushner, Mario Schlosser, Oscar, it's, Mark Bertolini, It's, Bertolini, Trump, Ari Gottlieb, Elijah Nouvelage, haven't Organizations: Service, Business, New, Morgan Healthcare, Aetna, Reuters, HRAs Locations: New York, ICHRAs

LONDON, Oct 9 (Reuters) - Government lawyers will on Monday tell Britain's top court that it should overturn a ruling which declared unlawful a plan to deport migrants to Rwanda, one of Prime Minister Rishi Sunak's key policies. The court ruled that those sent to Rwanda would be at risk of being sent home where they could face persecution despite having a legitimate asylum claim. This would make the policy unlawful under Britain's Human Rights Act (HRA), which made the European Convention on Human Rights (ECHR) part of British law. The decision dealt a massive blow to the Conservative Sunak's pledge to stop thousands of migrants from arriving in small boats on the English south coast. The government's first planned Rwanda deportation flight had been due to leave in June last year, but was blocked at the last minute by an injunction from the European Court of Human Rights until all the UK legal action had been concluded.

Persons: Britain's, Rishi Sunak's, Suella Braverman, Sunak, Joe Biden's, Michael Holden, Sam Tobin, Mark Heinrich Our Organizations: Appeal, European, Human Rights, Conservative, United, European Union, of Human Rights, Thomson Locations: Rwanda, London's, East Africa, Syria, Iraq, Iran, Vietnam, Sudan, Britain, Sunak's, West, United States, Mexico, Europe, Africa, Asia, Germany

☆ Over-the-Counter Birth Control Pills Are Coming. What Next? - The New York Times
▼ + stars: | 2023-07-19 | by ( Daniel Grossman | ) www.nytimes.com time to read: +2 min

Like many of my colleagues, I’ve been holding my breath for the last year, since HRA Pharma, which manufactures Opill, submitted its application to the F.D.A. We now have hope that other advances could be coming to help offset restrictions on minors’ access to contraception and state-level abortion bans. under President George W. Bush approved Plan B for over-the-counter sale, but only for people 18 or older. Because of the age restriction, the product was shunted behind the pharmacy counter, where the consumer’s age could be confirmed. asked Plan B’s sponsor for additional data on people 17 and younger to show the product could be used safely and effectively by adolescents.

Persons: Roe, — Opill, I’ve, Opill, George W, Bush Organizations: Food and Drug Administration, HRA Pharma

☆ FDA approves Opill, the first over-the-counter birth control pill
▼ + stars: | 2023-07-13 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

HRA Pharma expects a final decision by the FDA this summer on its application for nonprescription sales of Opill, which is generically called norgestrel. The Food and Drug Administration on Thursday approved the first over-the-counter birth control pill, a landmark decision that will allow more women and girls in the U.S. to prevent unintended pregnancies without a prescription. The daily pill, called Opill, was first approved by the FDA as a prescription in 1973. Medical organizations like the American College of Obstetricians and Gynecologists and women's health advocates have pushed for wider access. More than 50 members of Congress in March 2022 also called on FDA Commissioner Dr. Robert Califf to ensure the agency reviewed applications for over-the-counter birth control pills without delay.

Persons: Biden, Wade, –, Welgryn, Robert Califf, Patrizia Cavazzoni, Opill Organizations: HRA Pharma, FDA, Drug Administration, American College of Obstetricians, FDA's Center, Drug, Research Locations: U.S, Paris, Dublin

July 13 (Reuters) - The U.S. Food and Drug Administration on Thursday approved the first over-the-counter contraceptive pill, paving the way for millions of women in the country to purchase birth control without prescription. Perrigo will next week share its pricing plan for the pill, which will be available in stores and online in the first quarter of next year. Women should take a progestin-only pill within the same three hours every day to avoid pregnancy. The National Catholic Bioethics Center and other groups have opposed making Opill available without prescription, saying physicians should be involved in health decisions, especially for teenagers, along with parental supervision, to avoid harm. Perrigo gained the daily-use pill first through its $2.13 billion acquisition of Paris-based HRA Pharma in 2021.

Persons: Roe, Wade, Xavier Becerra, Opill, Jeffrey Singer, Perrigo, Manas Mishra, Sriparna Roy, Arun Koyyur Organizations: U.S . Food, Drug Administration, Perrigo, Human Services, Cato Institute, FDA, Catholic Bioethics Center, HRA Pharma, Thomson Locations: U.S, Paris, Bengaluru

☆ FDA advisors recommend sale of birth control pill without a prescription
▼ + stars: | 2023-05-10 | by ( Spencer Kimball | ) www.cnbc.com time to read: +3 min

A panel of experts who advise the Food and Drug Administration unanimously recommended Wednesday that the agency for the first time allow women to obtain a birth control pill without a prescription. The panel had been asked whether the benefits of selling HRA Pharma's birth control pill Opill outweighed the risks of consumers improperly using the medication resulting in unintended pregnancy. Medical associations such as the American College of Obstetricians and Gynecologists for years have urged over-the-counter sales of birth control pills be allowedMore than 50 members of Congress in March 2022 called on FDA Commissioner Dr. Robert Califf to ensure the agency reviewed applications for over-the-counter birth control pills without delay. "Despite decades of proven safety and effectiveness, people still face immense barriers to getting birth control due to systemic inequities in our healthcare system." Shrinking access to abortion across the U.S. in turn sparked renewed calls for expanded access to birth control to prevent unwanted pregnancies.

☆ A Birth Control Pill May Soon Be Available Over the Counter. Here’s What to Know.
▼ + stars: | 2023-05-10 | by ( Alisha Haridasani Gupta | ) www.nytimes.com time to read: +1 min

Food and Drug Administration advisers concluded that the benefits outweighed the risks of making a hormonal contraceptive pill — sold under the brand name Opill and produced by the French company HRA Pharma — available without a prescription. follows the nonbinding recommendation of its advisers — and there is a chance the agency might not — Opill would become the first and only birth control pill to be available over the counter since oral contraceptives were introduced in the U.S. in 1960. A 2022 survey found that 77 percent of more than 5,000 female participants favored the idea of getting the birth control pill over the counter, with many saying it would be more convenient and efficient to get it without a prescription. Progestin-only pills have been widely used in the United States since the first one was approved in 1973. Like other oral contraceptives, they require a prescription from a health care provider or, in some states, a pharmacist.

☆ F.D.A. Advisers Say Benefits of Over-the-Counter Birth Control Pill Outweigh Risks
▼ + stars: | 2023-05-10 | by ( Pam Belluck | ) www.nytimes.com time to read: +1 min

A panel of advisers to the Food and Drug Administration voted unanimously on Wednesday that the benefits of making a birth control pill available without a prescription outweigh the risks, a significant step in the decades-long push to make oral contraception obtainable over the counter in the United States. If the F.D.A. approves nonprescription sales of the medication, called Opill, this summer, it could significantly expand access to contraception, especially for young women and those who have difficulty dealing with the time, costs or logistical hurdles involved in visiting a doctor, reproductive health experts say. Approval is not a foregone conclusion, however. analysts also raised questions about whether younger adolescents and people with limited literacy could follow the directions.

☆ FDA may allow birth control pill without prescription this summer as experts weigh data
▼ + stars: | 2023-05-09 | by ( Spencer Kimball | ) www.cnbc.com time to read: +2 min

The Food and Drug Administration could approve the sale of birth control medication without a prescription for the first time by this summer. The FDA approved prescription sales of HRA Pharma's birth control pill in 1973. Medical associations such as the American College of Obstetricians and Gynecologists for years have supported over-the-counter access to birth control without age restrictions. In March 2022, more than 50 members of Congress urged FDA Commissioner Dr. Robert Califf to review applications for over-the-counter sales of birth control without delay. "Despite decades of proven safety and effectiveness, people still face immense barriers to getting birth control due to systemic inequities in our healthcare system."

☆ F.D.A. Advisers Weigh Allowing First U.S. Over-the-Counter Birth Control Pill
▼ + stars: | 2023-05-09 | by ( Pam Belluck | ) www.nytimes.com time to read: +1 min

It was like a tale of two birth control pills. At a hearing Tuesday to consider whether the Food and Drug Administration should authorize the country’s first over-the-counter birth control pill, a panel of independent medical experts advising the agency was left to reckon with two contradictory analyses of the medication called Opill. During the eight-hour session, the manufacturer of the pill, HRA Pharma, which is owned by Perrigo, and representatives of many medical organizations and reproductive health specialists said that data strongly supported approval. scientists questioned the reliability of company data that was intended to show that consumers would take the pill at roughly the same time every day and comply with directions to abstain from sex or temporarily use other birth control if they missed a dose. “I’m just really quite confused by the level of discrepancy,” one member of the advisory panel, Pamela Shaw, a senior investigator with Kaiser Permanente Washington, said after both sides had made presentations.

☆ Italy antitrust drops pricing probe into A2A and Hera, partially confirms for others
▼ + stars: | 2022-12-30 | by ( ) www.reuters.com time to read: +1 min

ROME, Dec 30 (Reuters) - Italy's antitrust authority on Friday said it had dropped its investigation into energy companies A2A (A2.MI) and Hera (HRA.MI) over suspected improper price-setting for gas and electricity. The agency also said its investigation into other utilities including Eni (ENI.MI) and Enel (ENEI.MI) would no longer cover price changes for contracts which had already expired or were due to expire. Eni, Enel as well as Edison (EDNn.MI), Acea (ACE.MI) and Engie (ENGIE.PA) remain under investigation for the alleged improper price-setting. The five energy companies were given five days to comply with an order to suspend all unilateral price changes they have introduced for open-ended contracts, with no clear or predetermined expiry date. Reporting by Alvise Armellini, additional reporting by Giancarlo Navach in Milan, editing by Louise Heavens, Kirsten DonovanOur Standards: The Thomson Reuters Trust Principles.

☆ Italy to scrap suspension of changes to expiring energy contracts -draft decree
▼ + stars: | 2022-12-28 | by ( ) www.reuters.com time to read: +1 min

ROME, Dec 28 (Reuters) - The Italian government plans to allow utilities to go ahead with changes to expiring gas and electricity supply contracts which the antitrust authority had suspended, according to a draft decree seen by Reuters. It will however extend by two months to June 30 a suspension to changes made to non-expiring contracts, the document read, as it seeks to help firms and households cope with soaring energy prices. It suspended the validity of contracts from Aug. 10 this year to April 30 2023 that allowed the companies to change their prices. In a statement on Dec. 14, Enel said it would appeal the watchdog's move and that changes to terms of expired and expiring contracts subject to a potential renewal should not be affected. Reporting by Giuseppe Fonte, writing by Federico Maccioni; editing by Emelia Sithole-MatariseOur Standards: The Thomson Reuters Trust Principles.

☆ Fact Check-Confusion spreads online about 15,000 people detained in Iran
▼ + stars: | 2022-11-17 | by ( Reuters Fact Check | ) www.reuters.com time to read: +4 min

CONFUSION SPREADSOn social media, the picture became blurred. Other social media users cited a Nov. 10 Newsweek article titled “Iran Protesters Refuse to Back Down as 15,000 Face Execution” as their source (here), (here), (here). Posts on social media conflated this with figures by local activist agencies that over 15,000 people had been detained. As of publication, death sentences have not been handed to 15,000 detained people. Read more about our work to fact-check social media posts here .

Search resuls for: "HRA"

14 mentions found